Adult Stem Cell Section, National Institute of Dental and Craniofacial Research (NIDCR), National Institutes of Health (NIH), Bethesda, MD, USA.
Oral Dis. 2018 Mar;24(1-2):67-71. doi: 10.1111/odi.12759.
In women with postmenopausal osteoporosis, vitamin K2 appears to decrease the incidence of hip, vertebral, and non-vertebral fractures. Women with postmenopausal osteoporosis have more circulating activated T cells compared with healthy postmenopausal and premenopausal women, but the effects of vitamin K2 on T cells have not been studied. In this study, we have looked at T-cell suppression by vitamin K2.
Peripheral blood mononuclear cells (PBMCs) from three healthy donors were used. The PBMCs were stimulated with the mitogens phytohemagglutinin and concanavalin A, and T-cell proliferation was analyzed using flow cytometry based on carboxyfluorescein succinimidyl ester (CSFE) dye dilution.
Vitamin K2 (60 and 100 μM) inhibited T-cell proliferation. Vitamin K1 at the same concentrations did not inhibit T-cell proliferation.
Vitamin K2 has immunomodulatory activities.
在绝经后骨质疏松症女性中,维生素 K2 似乎可降低髋部、椎体和非椎体骨折的发生率。与健康绝经后和绝经前女性相比,绝经后骨质疏松症女性的循环活化 T 细胞更多,但维生素 K2 对 T 细胞的影响尚未得到研究。在这项研究中,我们研究了维生素 K2 对 T 细胞的抑制作用。
使用了 3 名健康供体的外周血单核细胞 (PBMC)。用植物血球凝集素和伴刀豆球蛋白 A 刺激 PBMC,并使用基于羧基荧光素琥珀酰亚胺酯 (CSFE) 染料稀释的流式细胞术分析 T 细胞增殖。
维生素 K2(60 和 100μM)抑制 T 细胞增殖。相同浓度的维生素 K1 则不抑制 T 细胞增殖。
维生素 K2 具有免疫调节活性。